Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9Liver Neoplasms 2Liver Diseases 1Digestive System Diseases 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 3Capecitabine 3Irinotecan 2Gemcitabine 2Cyclophosphamide 2Colonoscopy 2Bupivacaine 2Aspirin 2Ascorbic Acid 2130-nm albumin-bound paclitaxel 2trifluridine tipiracil drug combination 1trametinib 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1hetrombopag 1halofantrine 1guadecitabine 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1enoxaparin sodium 1copper dotatate CU-64 1camrelizumab 1aumolertinib 1XELOX 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Digestive System Diseases × gadolinium ethoxybenzyl DTPA × Clear all
NCT02156739 2025-12-22

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

M.D. Anderson Cancer Center

Phase NA Active not recruiting
100 enrolled
Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡